Publications by authors named "Tiansu Lv"
Institutional Nomogram for Estimating Risk of Metabolic Associated Fatty Liver Disease (MAFLD).
Diabetes Metab Syndr Obes
October 2024
Article Synopsis
- Metabolic Associated Fatty Liver Disease (MAFLD) can lead to serious health issues, including liver fibrosis and cirrhosis, highlighting the need for early detection to improve chances of reversal, particularly through assessing body composition.
- A study conducted at the Jiangsu Province Hospital analyzed data from 513 patients, identifying independent risk factors for MAFLD and creating two nomograms, one of which integrated body composition data for enhanced predictive accuracy.
- The nomogram that included body composition demonstrated better predictive performance, allowing for more effective early identification of MAFLD risks, which is crucial for timely intervention.
The metabolic profiles and body composition of non-obese metabolic associated fatty liver disease.
Front Endocrinol (Lausanne)
February 2024
Background/purpose: Metabolic-associated fatty liver disease (MAFLD) is a major cause of chronic liver disease worldwide and is generally thought to be closely related to obesity and diabetes. However, it also affects non-obese individuals, particularly in Asian cultures.
Methods: Healthy physical examination subjects and MAFLD patients were included in the endocrinology department of Jiangsu Provincial Hospital of Traditional Chinese Medicine.
Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease.
Lipids Health Dis
February 2024
Steatotic liver disease poses a serious threat to human health and has emerged as one of the most significant burdens of chronic liver disease worldwide. Currently, the research mechanism is not clear, and there is no specific targeted drug for direct treatment. Phosphorylation is widely regarded as the most common type of protein modification, closely linked to steatotic liver disease in previous studies.
View Article and Find Full Text PDFBackground: Sex and reproductive status differences exist in both non-alcoholic fatty liver disease (NAFLD) and body composition. Our purpose was to investigate the relationship between body composition and the severity of liver steatosis and fibrosis in NAFLD in different sex and reproductive status populations.
Methods: This cross-sectional study included 880 patients (355 men, 417 pre-menopausal women, 108 post-menopausal women).
Article Synopsis
- The text indicates a correction to a scientific article identified by its DOI.
- The original article is published in the journal "Frontiers in Immunology."
- The specific details of the corrections made are not provided in the text itself.
Background: Some degree of platelet index abnormality has been found clinically in the autoimmune thyroid disease (AITD), but the findings are not uniform.
Methods: The PubMed, Web of Science, Cochrane Library, and Embase databases were searched for relevant articles published up to August 16th, 2022, with no restrictions on the language of the articles. Reference lists of eligible articles were also searched.